Company / Return on Assets (ROA)
Serina Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-276.0%
FY2025
5-year range
-322.8% / 78.4%
FY2021-FY2025
Trend
-452.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -452% YoY in FY2025, a notable deviation from the 6-year average annual change of -108%.
Based on SEC 10-K filings.
-276.0% in FY2025 with a 5-year CAGR of +33.7%.
Declined from 58.8% to -276.0% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +46.8pp
- 5-Year Change
- +33.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 452.2% year-over-year.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -276.0% | -452.2% |
| FY2024 | 78.4% | +33.4% |
| FY2023 | 58.8% | +118.2% |
| FY2022 | -322.8% | -17.4% |
| FY2021 | -275.1% | +11.2% |
| FY2020 | -309.7% | -340.5% |
| FY2018 | -70.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026